Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose (CROSBI ID 107221)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Jug, Mario ; Bećirević-Laćan, Mira Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose // Drug development and industrial pharmacy, 30 (2004), 10; 1051-1060-x

Podaci o odgovornosti

Jug, Mario ; Bećirević-Laćan, Mira

engleski

Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose

The purpose of the study was to investigate the effect of hydroxypropyl methylcellulose (HPMC) on the complexation of piroxicam (PX) with beta-cyclodextrin (beta-CD) and dimethyl-beta-cyclodextrin (DM-beta-CD) in solution and in the solid state. Phase solubility study revealed a positive effect of the polymer on the drug complexation. Improvement in stability constants values. Ks, of ternary complexes clearly proves the benefit of the HPMC addition for promoting higher complexation efficiency. Solid binary and ternary complexes were prepared by spray drying. Drug-CD and drug-CD-polymer interactions were studies in the solid state by differential scanning calorimetry (DSC)), zeta-potential measurements, and particle size distribution. A marked increase in the PX dissolution rate was observed even in binary and ternary complexes. The presence of HPMC in ternary complexes slightly retarded the release of PX. Cyclodextrin complexation increased the PX concentration gradient over the semipermeable membrane, resulting in an increased PX flux. The retarded diffusion of PX to the membrane interface decreased the PX to the membrane interface decreased th PX flux values of the ternary complexes.

piroxicam; cyclodextrins; hydroxypropyl methylcellulose; multicomponent complexes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

30 (10)

2004.

1051-1060-x

objavljeno

0363-9045

Povezanost rada

Farmacija

Indeksiranost